1.Tomatoes
1.1. Conventional tomatoes
Tomatoes are cultivated in North, Central and South America, and in Europe.
Ripening of the fruits is linked to production of ethylene. This triggers
a series of biochemical processes involving the formation of aroma and
taste properties and the production of valuable constituents (e.g. vitamins),
but also hastens degradation processes responsible for the softening of
the fruits.
Ripe, red tomatoes are too sensitive to endure long transport without
damage. This is why tomatoes are picked green, transported under refrigeration,
and treated at the destination with ethylene to trigger or accelerate
the final ripening process (in the United States, for example, over 80%
of the conventional tomatoes are picked in their unripened, green state).
While treatment with ethylene makes the tomatoes redden rapidly, the tomato
itself can never attain the aroma and flavour of one that has ripened
slowly on its stem.
1. 2. The FlavrSavr® tomato
The achievement of full ripening without softness is the aim of many
companies, not only in connection with tomatoes, but with many other vegetables
and fruits.
Calgene set out to produce a tomato that can ripen longer on the stem
and thereby attain its full aroma without getting soft, thereby enhancing
its transportability and storage properties. The result was the FlavrSavr®
tomato, the first genetically modified food to be granted a licence for
human consumption. It was introduced into the American marketplace in
1994.
The FlavrSavr® tomato was modified in such a way that the enzyme polygalacturonase
(PG), which is responsible for the tomato's softness, is no longer formed
in the tomato or else only in negligible quantities, meaning that the
tomato keeps longer.
The FlavrSavr® tomato differs from conventional tomatoes only in terms
of the delayed ripening process. There are no differences between the
FlavrSavr® tomato and conventional tomatoes as regards vitamins, protein,
and mineral substances. This is true for both the first generation as
well as for all subsequent generations of the FlavrSavr® tomato.
Nutrients per 100 g of tomatoes
Ingredient |
Natural range |
Flavr Savr® tomato |
Conventional tomatoes (controls) |
Protein |
0.85 g ±
0.015 g |
0.75-1.14 g |
0.53-1.05 g |
Vitamin A |
192-1667 IU |
330-1600 IU |
420-2200 IU |
Vitamin B1 (thiamine) |
16-80 µg |
38-72 µg |
39-64 µg |
Vitamin B2 (riboflavin) |
20-78 µg |
24-36 µg |
24-36 µg |
Vitamin B6 |
50-150 µg |
86-150 µg |
10-140 µg |
Vitamin C |
8.4-59 mg |
15.3-29.2 mg |
12.3-29.2 mg |
Niacin (nicotinic acid) |
0.3-0.85 mg |
0.43-0.70 mg |
0.43-0.76 mg |
Calcium |
4.0-21 mg |
9-13 mg |
10-12 mg |
Magnesium |
5.2-20.4 mg |
7-12 mg |
9-13 mg |
Phosphorus |
7.7-53 mg |
25-37 mg |
29-38 mg |
Sodium |
1.2-32.7 mg |
2-5 mg |
2-3 mg |
Iron |
0.2-0.95 mg |
0.2-0.41 mg |
0.26-0.42 mg |
Source: Trends in Food Science & Technology, Vol. 5, April 1994
1.3. Advantages of the FlavrSavr® tomato in comparison with conventional
tomatoes
The FlavrSavr® tomato can ripen on the stem and need not be picked green
and unripe as is the case for conventional tomatoes. During the ripening
process on the stem, the FlavrSavr® tomato can develop not only its colour,
but also its characteristic flavour properties and valuable constituents.
It can be transported unrefrigerated thereby saving energy. The FlavrSavr®
tomato reaches the consumer in an optically attractive state, with a fully
developed flavour and firm to the cut.
The British firm Zeneca, working with scientists from the University of
Nottingham, has also developed a tomato with a delayed ripening process.
It is particularly suited for the production of tomato pulp: since the
degradation of its cell walls is delayed, the pulp produced from this
tomato exhibits the desired viscosity. With conventional tomatoes the
degradation of the cell walls is prevented by heating, i.e. by destruction
of the PG enzyme. However, heating also destroys the aromatic substances.
The resultant tomato purée was sold by two chain stores only (selected
branches of Safeway and Sainsbury's supermarkets). It was first sold on
February 5th, 1996, with the GM purée outselling the conventional alternative
in some stores. The tomato purée was always clearly labelled. Both stores
pledged that they would always provide an alternative, conventional tomato
purée alongside the GM form.
The GM tomatoes were grown in California. They were not the same as the
US 'FlavrSavr®' (which is no longer produced). The GM tomatoes, which
were kept apart from the conventional type, were used for the purée only,
and were never put in any other products.
By March 1999, public reaction to GM foods forced Sainsbury's to announce
that they would no longer stock the purée once existing stocks ran out.
In July 1999, Sainsbury's removed any remaining cans from its shelves
(and all other own-label products that contained materials from GM sources),
following the announcement of rival high-street chain Marks and Spencer
that it was now 'GM free'. Safeway's stocks of the product had run out
some time before.
Overall the amount of energy required for the production of pulp from
transgenic tomatoes is lower. In the United States these energy savings
amount to approximately 100 million US dollars each year. Zeneca applied
for a licence for the marketing of this tomato variety in accordance with
Directive 90/220/EEC, via Spain in 1997. Approval is expected to be issued
in the future.
2. Rice
Rice is the most important nutritional crop worldwide. The annual harvest/crop
of rice is 570.6 million tons (status: 1999; source: FAS/USDA). It forms
the staple nutrition for over 2.2 billion people in Third World countries.
There will in all probability be a further one billion consumers of rice
in twenty years' time. Worldwide there are 230 million children and adolescents
who suffer from vitamin-A-deficiency disorders; such disorders result
in complete blindness in one million of these children and in the death
of a further million people each year. These people feed almost exclusively
on rice. Polished rice grains (white rice) contains neither vitamin A
nor provitamin A, the latter being converted into vitamin A in the body.
3.7 billion people suffer from iron-deficiency-related disorders (rice
contains proteins that inhibit the uptake of iron in the intestinal tract).
Various pests and diseases seriously affect the rice harvest:
-
The yellow rice borer (Tryproryza incertulas) destroys 20 to 25 million
tons of rice each year, an amount that could feed 100-125 million people.
-
Fungi destroy 20 to 40 million tons of rice each year; this amount
could feed 100-200 million people.
-
The Tungro virus destroys 5 to 10 million tons of rice each year;
this amount could feed 25-50 million people.
3. Cassava (manioc)
CCassava (also known as manioc) is cultivated in 92 countries worldwide.
It provides thtthe staple nutrition for 500 million people in Africa,
South America, and Southern InIIndia. The plant is capable of withstanding
prolonged periods of drought, grows evoften on barren soils, can be cultivated
and harvested at virtually any time of the
year, and can be easily propagated by taking cuttings.
It produces a large quantity of starch in its roots, which makes it attractive
as a nunutritional crop. Harvested cassava roots are, however, very sensitive
and start to decompose within the matter of only a few hours.
C Cassava plants form a substance that releases highly toxic cyanide.
While tratraditional processing methods (grating, washing out, pressing,
and roasting of cacassava flakes) can considerably reduce the cyanide
content, these tasks are
Highly time-consuming and work-intensive. Also, almost 25% of the harvest
yield is lo llost as a result of the mechanical processing. In many cases
it is not always popossible to completely eliminate the cyanide, resulting
in impairments of the flavour anand health risks. Cassava is also frequently
eaten in its raw state - especially by yoyoung children - and this can
naturally have life-endangering consequences.
YAA major part of the Cassava crop is also lost to pests and diseases.
Improving rice and cassava by genetic engineering
Genetic modification has been used successfully to develop rice varieties
that are resistant to the yellow rice borer, and to fungal infection.
Tungro virus-resistant rice varieties are currently undergoing trials.
Efforts are also being made to enhance the content of iron in rice and
to eliminate those substances that inhibit the uptake of iron in the intestinal
tract.
Phosphate is one of the most important nutrients for plants and in many
cases is the growth- limiting factor. Efforts are currently being made
to enhance the capacity of the rice plant to take up phosphate. Another
long-term objective is to incorporate the mechanism for nitrogen fixation
in rice and other grain crops of most commercial relevance so that they
no longer need be fertilized.
Long-term objectives of research efforts with cassava include effective
pest and disease containment and also the prevention of the formation
of cyanide and the rapid degradation process. Research along these lines
is currently in progress.
4. Bioplastics made from plants
Bioplastics produced from genetically modified plants could help reduce
the burden placed on the environment by conventional plastics. Much in
the same way as animals use fat as an energy store, certain bacteria use
substances similar to plastics. These can be isolated and processed into
bioplastic. In contrast to plastics conventionally manufactured from mineral
oil, bioplastics are produced from renewable resources such as vegetable
fats, oils, or carbohydrates. They are completely biodegradable and can
be used as a source of nutrients by a lot of naturally occuring microorganisms.
Bioplastic is still relatively expensive however, since the yield is very
small. Genetically modified bacteria or plants may in future be used for
industrial-scale production. Bioplastics could contribute in medicine;
particularly in surgery where body-compatible implants are called for,
or in the packaging-materials industry. The use of compostible shampoo
bottles, beverage cartons, baby diapers, and other packaging materials
could constitute an enormous reduction in the environmental burden imposed
by conventional plastics.
Since May 1997, the British Cooperative Bank has been offering credit
cards made of biodegradable plastic. The cards consist of "Biopol", a
bioplastic manufactured by Monsanto using microorganisms. Biopol is obtained
from renewable resources (e.g. sugar or vegetable fatty acids) and can
be disposed of by composting, being 99.9% free of the ecologically problematic
plastic PVC.
Employing genetic-modification methods Monsanto has also developed plants
(oilseed rape) that produce relatively small amounts of Biopol (5% of
the total weight) in their cells. The ultimate aim is to develop plants
that consist of up to 20% by weight of Biopol, thereby enabling various
bioplastics to be produced for a wide variety of applications.
5. Plants that degrade and are resistant towards deleterious substances
Genetic modification not only offers assistance in avoiding environmental
damage - it can also be applied to relieve ecological damage that has
already occurred, by using microorganisms or plants that degrade various
pollutants.
The methods traditionally used to eliminate industrial pollution are limited:
contaminated soils for example, are excavated and deposited at waste dumps
or else incinerated in special facilities. In both cases the transport
costs involved are high, and the humus - which is important for the fertility
of the soil - is lost in the process. When the soils are deposited, the
pollutants are not destroyed, they are merely removed from the public
eye, and the threat is merely postponed. In built-up areas, it is often
impossible or at least extremely difficult to remove contaminated materials.
Bio-remediation constitutes an efficient, ecologically compatible, and
inexpensive alternative to traditional techniques. Ideally, these methods
enable the pollutants to be degraded into inorganic compounds in situ
in the soil or groundwater using naturally occurring microorganisms.
Aluminium-tolerant plants: Many soils worldwide are contaminated with
aluminium, with the result that harvest yields are severely reduced. A
Mexican research team has transferred the gene for an enzyme responsible
for the development of citric acid to various plants, such as, papaya
and tobacco. Compared with normal plants, these exhibit significantly
better growth in aluminium-contaminated soils. While this should not detract
from the importance of avoiding contamination of soils with aluminium
in the first place, plants such as these could one day play a decisive
role in solving problems where such contamination has already occurred.
In another development, American scientists at the University of Georgia
have succeeded in cultivating mustard plants that have the ability to
take up mercury and convert it into a chemical compound that is far less
damaging to the environment. If the results of the laboratory experiments
translate into practice, in future it might be possible to clean up mercury-contaminated
soils by the cultivation of such plants instead of having to deposit these
soils in special waste dumps.
6. Pharmaceutical drugs produced by plants
Plants can also be genetically modified such that they are capable of
producing vaccines, pharmaceutical agents, or other therapeutically valuable
proteins. No such products are on the market yet, but research efforts
in this area are already well underway.
Human glucocerebrosidase (HCG) is used in the treatment of Gaucher patients
(a congenital metabolic disorder). This is currently the most expensive
pharmaceutical drug worldwide, costing about 160,000 US dollars per patient
per year. The pharmaceutical agent is administered to the patient at one-
to two-week intervals. The dose used corresponds to an equivalent of roughly
2,000 placentae from which the human protein is isolated. Since 1997,
Genzyme who produce this drug, have been using genetically modified mammal
cells as an alternative means of production. This has not yet resulted
in a reduction in the price of the pharmaceutical product however. The
corresponding gene has also been transferred to tobacco plants, achieving
excellent results: one single tobacco plant produces the quantity required
for an entire weekly dose. It therefore looks likely that it will be possible
to produce the drug in greater quantities and more inexpensively in future.
Cholera vaccine from bananas: Efforts are currently being made to modify
bananas such that they are capable of producing a vaccine against cholera.
This vaccine would have the advantage of being ready-packed (in its skin),
having a natural expiry date (the rotting of the banana), being easy to
administer (eating the banana), and being able to be produced where it
is required (in Third-World countries) in an environmentally sparing manner.
Other examples
| Pharmaceutical drug |
Plant |
| Hemoglobin |
Tobacco |
| Malaria vaccine |
Tobacco |
| Antibiotic |
Tobacco |
| Monoclonal antibodies |
Soybean |
| Hemoproteins |
Maize |
| Proteins against autoimmune disorders |
Maize |
| Caries vaccine |
Tobacco |

Back to Info Kit main page |